{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:47:09Z","timestamp":1792784829551,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This research was funded by the Antenna Foundation.","id":[{"id":"https:\/\/ror.org\/02hxa8728","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    <jats:italic>Hibiscus sabdariffa<\/jats:italic>\n                    is effective against hypertension in clinical trials, with a dose-response effect, making it an important, accessible and sustainable treatment. The aim of the present work was to clarify the influence of origin of Hibiscus on clinical effect and decoction time on the yield of active substances, in order to issue recommendations for use. This study reviewed blood pressure progress in three clinical trials after 3-4 weeks of Hibiscus tea consumption, with batches analyzed for total anthocyanins (TA) and hibiscus acid (HA), the 2 known active substances, with two different decoction times (10 vs 20\u2009min). HA levels appeared consistent across batches for a given decoction time, whereas TA levels varied up to 4-fold. Despite this variation, clinical outcomes remained similar. Quantities of TA extracted increased with a longer decoction time. These results suggest that the batch of Hibiscus does not significantly influence its antihypertensive activity, and that HA is a main active principle. Thus, a future perspective of this work could be the development of a more available method, other than NMR, for the characterization of the HA content. Clinical practice should involve adjusting Hibiscus dosage based on individual BP response. Starting treatment with, instead of 10\u2009g, 2.5\u2009g\/day and adjusting as needed is recommended, and a 20\u2009min decoction remains advisable. HS decoctions can be recommended for broad BP control thanks to their safety and effectiveness.\n                  <\/jats:p>","DOI":"10.1038\/s41371-026-01233-7","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:20:58Z","timestamp":1791289258000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is the antihypertensive activity of Hibiscus sabdariffa affected by factors such as origin of the plant and time of decoction? Implications for clinical practice"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6723-2274","authenticated-orcid":false,"given":"Anne-Laure","family":"Cavin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Marcourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"F\u00e9lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0533-5546","authenticated-orcid":false,"given":"Nicolas Vinh Tri","family":"Low-Der\u2019s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Campos Nogueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwah","family":"Al-Anbaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson","family":"Ferreira Queiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0125-952X","authenticated-orcid":false,"given":"Jean-Luc","family":"Wolfender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Graz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"key":"1233_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/s0378-8741(98)00157-3","volume":"65","author":"HM Faraji","year":"1999","unstructured":"Faraji HM, Tarkhani HA. The effect of sour tea (Hibiscus sabdariffa) on essential hypertension. J Ethnopharmacol. 1999;65:231\u20136. https:\/\/doi.org\/10.1016\/s0378-8741(98)00157-3","journal-title":"J Ethnopharmacol"},{"key":"1233_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.phymed.2004.04.001","volume":"11","author":"A Herrera-Arellano","year":"2004","unstructured":"Herrera-Arellano A, Flores-Romero S, Ch\u00e1vez-Soto MA, Tortoriello J. Effectiveness and tolerability of a standardized extract from Hibiscus sabdariffa in patients with mild to moderate hypertension: a controlled and randomized clinical trial. Phytomedicine Int J Phytother Phytopharm. 2004;11:375\u201382. https:\/\/doi.org\/10.1016\/j.phymed.2004.04.001","journal-title":"Phytomedicine Int J Phytother Phytopharm"},{"key":"1233_CR3","doi-asserted-by":"publisher","first-page":"540","DOI":"10.4103\/0253-7613.165194","volume":"47","author":"DC Nwachukwu","year":"2015","unstructured":"Nwachukwu DC, Aneke EI, Obika LF, Nwachukwu NZ. Effects of aqueous extract of Hibiscus sabdariffa on the renin-angiotensin-aldosterone system of Nigerians with mild to moderate essential hypertension: a comparative study with lisinopril. Indian J Pharmacol. 2015;47:540\u20135. https:\/\/doi.org\/10.4103\/0253-7613.165194","journal-title":"Indian J Pharmacol"},{"key":"1233_CR4","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/nutrit\/nuab104","volume":"80","author":"LR Ellis","year":"2022","unstructured":"Ellis LR, Zulfiqar S, Holmes M, Marshall L, Dye L, Boesch C. A systematic review and meta-analysis of the effects of Hibiscus sabdariffa on blood pressure and cardiometabolic markers. Nutr Rev. 2022;80:1723\u201337. https:\/\/doi.org\/10.1093\/nutrit\/nuab104","journal-title":"Nutr Rev"},{"key":"1233_CR5","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1097\/FJC.0000000000001161","volume":"79","author":"M Abdelmonem","year":"2022","unstructured":"Abdelmonem M, Ebada MA, Diab S, Ahmed MM, Zaazouee MS, Essa TM, et al. Efficacy of hibiscus sabdariffa on reducing blood pressure in patients with mild-to-moderate hypertension: a systematic review and meta-analysis of published randomized controlled trials. J Cardiovasc Pharmacol. 2022;79:e64\u201374. https:\/\/doi.org\/10.1097\/FJC.0000000000001161","journal-title":"J Cardiovasc Pharmacol"},{"key":"1233_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2025.103135","volume":"89","author":"M Norouzzadeh","year":"2025","unstructured":"Norouzzadeh M, Hasan Rashedi M, Azizi MH, Teymoori F, Maghsoomi Z, Shidfar F. Efficacy and safety of Hibiscus sabdariffa in cardiometabolic health: an overview of reviews and updated dose-response meta-analysis. Complement Ther Med. 2025;89:103135 https:\/\/doi.org\/10.1016\/j.ctim.2025.103135","journal-title":"Complement Ther Med"},{"key":"1233_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2022.102409","volume":"16","author":"O Eslami","year":"2022","unstructured":"Eslami O, Khorramrouz F, Ghavami A, Hajebi Khaniki S, Shidfar F. Effect of cherry consumption on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr Clin Res Rev. 2022;16:102409 https:\/\/doi.org\/10.1016\/j.dsx.2022.102409","journal-title":"Diabetes Metab Syndr Clin Res Rev"},{"key":"1233_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s40292-021-00456-8","volume":"28","author":"A Lari","year":"2021","unstructured":"Lari A, Fatahi S, Sohouli MH, Shidfar F. The impact of chromium supplementation on blood pressure: a systematic review and dose\u2013response meta\u2011analysis of randomized\u2011controlled trials. High Blood Press Cardiovasc Prev. 2021;28:333\u201342. https:\/\/doi.org\/10.1007\/s40292-021-00456-8","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"1233_CR9","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/ptr.6254","volume":"33","author":"A Asadi","year":"2019","unstructured":"Asadi A, Shidfar F, Safari M, Hosseini AF, Fallah Huseini H, Heidari I, et al. Efficacy of Melissa officinalis L. (lemon balm) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: a randomized, double\u2010blind, clinical trial. Phytother Res. 2019;33:651\u20139. https:\/\/doi.org\/10.1002\/ptr.6254","journal-title":"Phytother Res"},{"key":"1233_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41371-017-0001-6","volume":"32","author":"SM Seck","year":"2017","unstructured":"Seck SM, Doupa D, Dia DG, Diop EA, Ardiet DL, Nogueira RC, et al. Clinical efficacy of African traditional medicines in hypertension: a randomized controlled trial with Combretum micranthum and Hibiscus sabdariffa. J Hum Hypertens. 2017;32:1 https:\/\/doi.org\/10.1038\/s41371-017-0001-6","journal-title":"J Hum Hypertens"},{"key":"1233_CR11","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/s41371-020-00415-1","volume":"35","author":"A Bourqui","year":"2021","unstructured":"Bourqui A, Niang EAB, Graz B, Diop EA, Dahaba M, Thiaw I, et al. Hypertension treatment with Combretum micranthum or Hibiscus sabdariffa, as decoction or tablet: a randomized clinical trial. J Hum Hypertens. 2021;35:800\u20138. https:\/\/doi.org\/10.1038\/s41371-020-00415-1","journal-title":"J Hum Hypertens"},{"key":"1233_CR12","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1089\/acm.2019.0220","volume":"25","author":"Al-Anbaki","year":"2019","unstructured":"Al-Anbaki, Nogueira M, Cavin AL RC, Al-Hadid M, Al-Ajlouni I, Shuhaiber L, et al. Treating uncontrolled hypertension with hibiscus sabdariffa when standard treatment is insufficient: pilot intervention. J Altern Complement Med. 2019;25:1200\u20135.","journal-title":"J Altern Complement Med"},{"key":"1233_CR13","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3390\/plants10051018","volume":"10","author":"Al-Anbaki","year":"2021","unstructured":"Al-Anbaki, Cavin AL M, Nogueira RC, Taslimi J, Ali H, Najem M, et al. Hibiscus sabdariffa, a treatment for uncontrolled hypertension. pilot comparative intervention. Plants Basel Switz. 2021;10:1018 https:\/\/doi.org\/10.3390\/plants10051018","journal-title":"Plants Basel Switz"},{"key":"1233_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.fitote.2019.01.012","volume":"134","author":"AM Zheoat","year":"2019","unstructured":"Zheoat AM, Gray AI, Igoli JO, Ferro VA, Drummond RM. Hibiscus acid from Hibiscus sabdariffa (Malvaceae) has a vasorelaxant effect on the rat aorta. Fitoterapia. 2019;134:5\u201313. https:\/\/doi.org\/10.1016\/j.fitote.2019.01.012","journal-title":"Fitoterapia"},{"key":"1233_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.jep.2009.09.059","volume":"127","author":"D Ojeda","year":"2010","unstructured":"Ojeda D, Jim\u00e9nez-Ferrer E, Zamilpa A, Herrera-Arellano A, Tortoriello J, Alvarez L. Inhibition of angiotensin convertin enzyme (ACE) activity by the anthocyanins delphinidin- and cyanidin-3-O-sambubiosides from Hibiscus sabdariffa. J Ethnopharmacol. 2010;127:7\u201310. https:\/\/doi.org\/10.1016\/j.jep.2009.09.059","journal-title":"J Ethnopharmacol"},{"key":"1233_CR16","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.foodchem.2014.05.002","volume":"165","author":"I Da-Costa-Rocha","year":"2014","unstructured":"Da-Costa-Rocha I, Bonnlaender B, Sievers H, Pischel I, Heinrich M. Hibiscus sabdariffa L. - a phytochemical and pharmacological review. Food Chem. 2014;165:424\u201343. https:\/\/doi.org\/10.1016\/j.foodchem.2014.05.002","journal-title":"Food Chem"},{"key":"1233_CR17","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1055\/s-0032-1327864","volume":"78","author":"E Jim\u00e9nez-Ferrer","year":"2012","unstructured":"Jim\u00e9nez-Ferrer E, Alarc\u00f3n-Alonso J, Aguilar-Rojas A, Zamilpa A, Jim\u00e9nez-Ferrer C I, Tortoriello J, et al. Diuretic effect of compounds from Hibiscus sabdariffa by modulation of the aldosterone activity. Planta Med. 2012;78:1893\u20138. https:\/\/doi.org\/10.1055\/s-0032-1327864","journal-title":"Planta Med"},{"key":"1233_CR18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/jhh.2014.46","volume":"29","author":"IJ Onakpoya","year":"2015","unstructured":"Onakpoya IJ, Spencer EA, Thompson MJ, Heneghan CJ. The effect of chlorogenic acid on blood pressure: a systematic review and meta-analysis of randomized clinical trials. J Hum Hypertens. 2015;29:77\u201381. https:\/\/doi.org\/10.1038\/jhh.2014.46","journal-title":"J Hum Hypertens"},{"key":"1233_CR19","doi-asserted-by":"publisher","first-page":"113","DOI":"10.54548\/njps.v37i1.14","volume":"37","author":"P Ugwu","year":"2022","unstructured":"Ugwu P, Ubom R, Madueke P, Okorie P, Nwachukwu D. Anti-hypertensive effects of anthocyanins from hibiscus sabdarifa calyx on the renin-angiotensin-aldoslestrone system in wistar rats. Niger J Physiol Sci Off Publ Physiol Soc Niger. 2022;37:113\u20137. https:\/\/doi.org\/10.54548\/njps.v37i1.14","journal-title":"Niger J Physiol Sci Off Publ Physiol Soc Niger"},{"key":"1233_CR20","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/bmc.3623","volume":"30","author":"J Wang","year":"2016","unstructured":"Wang J, Cao X, Ferchaud V, Qi Y, Jiang H, Tang F, et al. Variations in chemical fingerprints and major flavonoid contents from the leaves of thirty\u2010one accessions of Hibiscus sabdariffa L. Biomed Chromatogr. 2016;30:880\u20137. https:\/\/doi.org\/10.1002\/bmc.3623","journal-title":"Biomed Chromatogr"},{"key":"1233_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.pnmrs.2010.05.001","volume":"57","author":"U Holzgrabe","year":"2010","unstructured":"Holzgrabe U. Quantitative NMR spectroscopy in pharmaceutical applications. Prog Nucl Magn Reson Spectrosc. 2010;57:229\u201340. https:\/\/doi.org\/10.1016\/j.pnmrs.2010.05.001","journal-title":"Prog Nucl Magn Reson Spectrosc"},{"key":"1233_CR22","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/biomedicines8050100","volume":"8","author":"J Izquierdo-Vega","year":"2020","unstructured":"Izquierdo-Vega J, Arteaga-Badillo D, S\u00e1nchez-Guti\u00e9rrez M, Morales-Gonz\u00e1lez J, Vargas-Mendoza N, G\u00f3mez-Aldapa C, et al. Organic acids from roselle (Hibiscus sabdariffa L.)\u2014a brief review of its pharmacological effects. Biomedicines. 2020;8:100 https:\/\/doi.org\/10.3390\/biomedicines8050100","journal-title":"Biomedicines"},{"key":"1233_CR23","doi-asserted-by":"publisher","first-page":"e0261924","DOI":"10.1371\/journal.pone.0261924","volume":"17","author":"A Sanou","year":"2022","unstructured":"Sanou A, Konate K, Dakuyo R, Kabore K, Sama H, Dicko MH. Hibiscus sabdariffa: Genetic variability, seasonality and their impact on nutritional and antioxidant properties. PloS One. 2022;17:e0261924 https:\/\/doi.org\/10.1371\/journal.pone.0261924","journal-title":"PloS One"},{"key":"1233_CR24","doi-asserted-by":"publisher","unstructured":"Para\u00edso CM, Dos Santos SS, Langer Ogawa CY, Sato F, Santos OAAD, Madrona GS Hibiscus sabdariffa l. extract: characterization (FTIR-ATR), storage stability and food application. Emir J Food Agric. 2020;55. https:\/\/doi.org\/10.9755\/ejfa.2020.v32.i1.2059","DOI":"10.9755\/ejfa.2020.v32.i1.2059"},{"key":"1233_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1055\/s-2006-957065","volume":"73","author":"A Herrera-Arellano","year":"2007","unstructured":"Herrera-Arellano A, Miranda-S\u00e1nchez J, Avila-Castro P, Herrera-Alvarez S, Jim\u00e9nez-Ferrer JE, Zamilpa A, et al. Clinical effects produced by a standardized herbal medicinal product of Hibiscus sabdariffa on patients with hypertension. a randomized, double-blind, lisinopril-controlled clinical trial. Planta Med. 2007;73:6\u201312. https:\/\/doi.org\/10.1055\/s-2006-957065","journal-title":"Planta Med"},{"key":"1233_CR26","unstructured":"Pharmacop\u00e9e F Dosage des anthocyanosides dans la Vigne Rouge (Vitis vinifera). 11\u00e8me. Saint-Denis, France; ANSN: 1996."},{"key":"1233_CR27","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1271\/bbb.69.1555","volume":"69","author":"H Hida","year":"2005","unstructured":"Hida H, Yamada T, Yamada Y. Production of hydroxycitric acid by microorganisms. Biosci Biotechnol Biochem. 2005;69:1555\u201361. https:\/\/doi.org\/10.1271\/bbb.69.1555","journal-title":"Biosci Biotechnol Biochem"},{"key":"1233_CR28","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780199689903.001.0001","volume-title":"Oxford handbook of clinical medicine","author":"I Wilkinson","year":"2017","unstructured":"Wilkinson I, Raine T, Wiles K, Goodhart A, Hall C, O\u2019Neill H. Oxford handbook of clinical medicine. Tenth edition. Oxford: Oxford University Press; 2017.","edition":"Tenth edition"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01233-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01233-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01233-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:20:59Z","timestamp":1791289259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01233-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":28,"alternative-id":["1233"],"URL":"https:\/\/doi.org\/10.1038\/s41371-026-01233-7","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"30 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations. Ethics approval was not needed for the present work as we are comparing previously published clinical studies for which ethics approval and informed consent were already mentioned in the corresponding articles. Furthermore, no animal studies were conducted for this study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}